Seladelpar improves key liver function markers in PBC
A relatively new therapy, seladelpar, has an acceptable efficacy and safety profile in the treatment of PBC.
Ryner Lai, MBBS
Ryner Lai, MBBS is a UK medical graduate who practiced medicine in Malaysia. He has a keen interest in rare diseases, quality of life, and the social drivers of global healthcare inequities. He believes in the power of medical communications to improve clinical decision-making and highlight the patient experience.
